1. Managing Childhood Chickenpox

   • Philip A. Brunell

   Guest Editorial 25 November 2012 Pages: 91 - 93

2. Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux Disease

   • C. M. Bate
   • P. D. I. Richardson

   Leading Article 25 November 2012 Pages: 94 - 99

3. Health Economics in Primary Care in the UK

   • T. Walley
   • R. T. Edwards

   Leading Article 25 November 2012 Pages: 100 - 106

4. Pharmacoeconomics of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

   • Hilary A. Wynne
   • Mark Campbell

   Review Article 25 November 2012 Pages: 107 - 123

5. Economic Aspects of General Anaesthesia

   • S. P. Rhodes
   • S. Ridley

   Review Article 25 November 2012 Pages: 124 - 130

6. Cost-Effectiveness Study of a Lipid-Lowering Therapy in Hyperlipoproteinaemia Type IIb and Type IV (Frederickson)

   • Rito Bergemann
   • Arno Brandt
   • Walter Siegrist

   Original Research Article 25 November 2012 Pages: 131 - 139

7. Misoprostol

   • Lee B. Barradell
   • Ruth Whittington
   • Paul Benfield

   Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 140 - 171

8. Impact of Triplicate Prescribing Programme on Psychotropic Prescribing

   • Annet Bedikian
   • Mark A. Gill

   Current Comment 25 November 2012 Pages: 172 - 173

9. Cost Savings with Antacid Treatment?

   • D. W. Piper

   Current Comment 25 November 2012 Pages: 173 - 175

10. COPD Education Reduces Consumption of Healthcare Services

    • Birthe Sendergaard
    • Hillerød Rasmussen
    • Mette Rasmussen

    Current Comment 25 November 2012 Pages: 175 - 177